Back to Journals » Lung Cancer: Targets and Therapy » Volume 13
Commentary
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
ORIENT-31 as the Sakigake “Charging Samurai” Born of IMpower150 but Will MARIPOSA-2 IMPRESS in the “Meiji Modernization” of Post-3G EGFR TKI Progression?
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
8,322 | Dovepress* | 7,501+ | 368 | 7,869 | |
PubMed Central* | 821 | 321 | 1,142 | ||
Totals | 8,322 | 689 | 9,011 | ||
*Since 29 March 2022 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
6 | 0 | 0 | 0 | 3 | 3 |
View citations on PubMed Central and Google Scholar